Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Mar;52(3):228–230. doi: 10.1136/jcp.52.3.228

A first British case of fish-eye disease presenting at age 75 years: a double heterozygote for defined and new mutations affecting LCAT structure and expression.

A F Winder 1, J S Owen 1, P H Pritchard 1, D Lloyd-Jones 1, D T Vallance 1, P White 1, R Wray 1
PMCID: PMC501085  PMID: 10450185

Abstract

Fish-eye disease is a familial syndrome with corneal opacification, major high density lipoprotein (HDL) deficiency in plasma, significant cholesterol esterification in plasma on non-HDL lipoproteins, generally without premature coronary disease. This first British male case from unrelated British parents had infarcts when aged 49 and 73 years but was asymptomatic at age 81 years, with plasma cholesterol 4.3-7.1 mmol/litre, triglycerides 1.8-2.2 mmol/litre, HDL cholesterol < 0.1 mmol/litre, apolipoprotein A-I < 0.16 g/litre, lipoprotein(a) 0.61 g/litre. Cholesterol esterification was impaired using HDL-3 and A-I proteoliposomes but not using VLDL/IDL/LDL. The findings are those of LCAT deficiency with the classic fish-eye disease defect. Most of the 22 reported cases were homozygous or heterozygous for a Thr-Ile mutation at codon 123 of the lecithin:cholesterol acyltransferase (LCAT) gene. This patient was a double heterozygote for this mutation and a second new incompletely defined mutation affecting LCAT expression as defined by reduced mass and activity in plasma.

Full text

PDF
228

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen C. H., Albers J. J. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity. J Lipid Res. 1982 Jul;23(5):680–691. [PubMed] [Google Scholar]
  2. Frohlich J., Hoag G., McLeod R., Hayden M., Godin D. V., Wadsworth L. D., Critchley J. D., Pritchard P. H. Hypoalphalipoproteinemia resembling fish eye disease. Acta Med Scand. 1987;221(3):291–298. doi: 10.1111/j.0954-6820.1987.tb00896.x. [DOI] [PubMed] [Google Scholar]
  3. Kuivenhoven J. A., Pritchard H., Hill J., Frohlich J., Assmann G., Kastelein J. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res. 1997 Feb;38(2):191–205. [PubMed] [Google Scholar]
  4. Kuivenhoven J. A., van Voorst tot Voorst E. J., Wiebusch H., Marcovina S. M., Funke H., Assmann G., Pritchard P. H., Kastelein J. J. A unique genetic and biochemical presentation of fish-eye disease. J Clin Invest. 1995 Dec;96(6):2783–2791. doi: 10.1172/JCI118348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Philipson B. T. Fish eye disease. Birth Defects Orig Artic Ser. 1982;18(6):441–448. [PubMed] [Google Scholar]
  6. Winder A. F., Garner A., Sheraidah G. A., Barry P. Familial lecithin:cholesterol acyltransferase deficiency. Biochemistry of the cornea. J Lipid Res. 1985 Mar;26(3):283–287. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES